122 related articles for article (PubMed ID: 7598360)
1. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers.
Welkoborsky HJ; Hinni M; Dienes HP; Mann WJ
Ann Otol Rhinol Laryngol; 1995 Jul; 104(7):503-10. PubMed ID: 7598360
[TBL] [Abstract][Full Text] [Related]
2. [Anneroth, Batsakis and Luna's modified classification as prognostic factor in patients with laryngeal carcinoma].
Starska K; Kulig A; Łukomski M
Otolaryngol Pol; 2003; 57(2):229-35. PubMed ID: 12894429
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer.
Morawski K; Gabriel A; Namyslowski G; Ziólkowski A; Pietrawska V; Steplewska K
Eur Arch Otorhinolaryngol; 1999; 256(8):378-83. PubMed ID: 10525938
[TBL] [Abstract][Full Text] [Related]
4. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
Broich G; Lavezzi AM; Biondo B; Pignataro LD
In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
[TBL] [Abstract][Full Text] [Related]
5. Expression of p27 and PTEN and clinical characteristics in early laryngeal squamous cell carcinoma and their correlation with recurrence.
Yang JQ; Liang Z; Wu M; Sun YM; Liu HX
Int J Clin Exp Pathol; 2015; 8(5):5715-20. PubMed ID: 26191286
[TBL] [Abstract][Full Text] [Related]
6. [Value of monoclonal antibodies (PC 10, MIB1, p53 and LeuM 1) for assessing the prognosis of patients with squamous epithelial carcinoma of the larynx after partial laser resection].
Hake R; Eckel H; von Pritzbuer E; Volling P; Thiele J
Pathologe; 1995 May; 16(3):197-203. PubMed ID: 7792271
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
8. DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.
Cappiello J; Nicolai P; Antonelli AR; Facchetti F; Cadei M; Cornacchiari A; Grigolato PG
Eur Arch Otorhinolaryngol; 1995; 252(6):353-8. PubMed ID: 8679155
[TBL] [Abstract][Full Text] [Related]
9. [The proliferative activity of laryngeal carcinoma and its relationship to histological malignancy and prognosis].
Zhang Q; Li Y; Liu J
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(5):305-7. PubMed ID: 8762515
[TBL] [Abstract][Full Text] [Related]
10. Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma.
Bradford CR; Wolf GT; Carey TE; Zhu S; Beals TF; Truelson JM; McClatchey KD; Fisher SG
Otolaryngol Head Neck Surg; 1999 Nov; 121(5):534-8. PubMed ID: 10547465
[TBL] [Abstract][Full Text] [Related]
11. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
Zidar N; Gale N; Cör A; Kambic V
J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
[TBL] [Abstract][Full Text] [Related]
12. [Tumor biologic prognostic parameters in T1N0M0 squamous cell carcinoma of the oral cavity].
Welkoborsky HJ; Gluckman JL; Jacob R; Bernauer H; Mann W
Laryngorhinootologie; 1999 Mar; 78(3):131-8. PubMed ID: 10226980
[TBL] [Abstract][Full Text] [Related]
13. [Expression of EGFR and PCNA, and DNA content in squamous cell carcinoma of larynx].
Ling L; Zhou MY; Wang HE
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Mar; 14(3):99-101. PubMed ID: 12541404
[TBL] [Abstract][Full Text] [Related]
14. Protein marker profiling in different T classification in laryngeal squamous cell carcinoma.
Chen W; Ye F; Cui M; Sikora AG; Wang X; Wang P; Cui X; Guo X; Zhu W; Zhang DY
Head Neck; 2015 Mar; 37(3):357-65. PubMed ID: 24753215
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
[TBL] [Abstract][Full Text] [Related]
16. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
May M; Burger M; Otto W; Hakenberg OW; Wieland WF; May D; Hofstädter F; Götz S; Niessl N; Fritsche HM; Birnkammer K; Gilfrich C; Peter J; Jain A; Koch S; Lebentrau S; Riedmiller H; Rössler W; Denzinger S; Brookman-May S; Gunia S
BJU Int; 2013 Aug; 112(4):E383-90. PubMed ID: 23305250
[TBL] [Abstract][Full Text] [Related]
17. [Histological clinical features of the primary tumor as prognostic factors in patients with laryngeal carcinoma].
Starska K; Kulig A; Łukomski M
Pol Merkur Lekarski; 2003 Jul; 15(85):55-60. PubMed ID: 14593961
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
[TBL] [Abstract][Full Text] [Related]
19. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of squamous cell carcinomas of the head and neck--analysis of tumor biologic factors and proliferation rates.
Jacob R; Welkoborsky HJ; Mann WJ; Höfken F; Dienes HP; Freije JE
Laryngoscope; 1996 Sep; 106(9 Pt 1):1170-5. PubMed ID: 8822725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
